Benefit of thrombolytic therapy is sustained throughout five years and is related to TIMI perfusion grade 3 but not grade 2 flow at discharge. The European Cooperative Study Group.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples